Abstract
Pancreatic metastases account for 2-5 % of all pancreatic malignancies and challenge differential diagnosis versus primary pancreatic neoplasia. EUS fine needle aspiration (FNA) shows the greatest accuracy in the differential diagnosis of pancreatic masses. However, EUS-FNA may suffer from suboptimal sensitivity and low but not negligible rate of complications. Recently, CH-EUS has been reported as an useful adjunct in differential diagnosis of pancreatic tumors. Our aim was to evaluate the potential role of CH-EUS in the differential diagnosis of pancreatic metastases.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
